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CattlePicornavirus RNA replication is initiated by a small viral protein primer, 3B (also known as VPg), that is
covalently linked to the 5' terminus of the viral genome. In contrast to other picornaviruses that encode a
single copy of 3B, foot-and-mouth disease virus (FMDV) encodes three copies of 3B. Viruses containing
disrupted native sequence or deletion of one of their three 3B proteins were derived from a FMDV A24
Cruzeiro full-length cDNA infectious clone. Mutant viruses had growth characteristics similar to the parental
virus in cells. RNA synthesis and protein cleavage processes were not signiﬁcantly affected in these mutant
viruses. Cattle infected by aerosol exposure with mutant viruses developed clinical disease similar to that
caused by the parental A24 Cruzeiro. Therefore, severe domain disruption or deletion of individual 3B
proteins in FMDV do not affect the virus' ability to replicate in vitro and cause clinical disease in cattle.riguez).
Inc.Published by Elsevier Inc.Introduction
Foot-and-mouth disease (FMD) is a highly contagious viral disease of
cattle, pigs, sheep, goats, and wild cloven-hoofed animals. The disease is
characterized by fever and vesicular lesions of the epithelium of the
mouth, tongue, feet, and teats (Alexandersen et al., 2003). The causal
agent, FMDvirus (FMDV), is a positive-strandedRNAvirus that is the type
species of the Aphthovirus genus of the Picornaviridae family.
The 8-kb FMDV genome is involved in translation and in replication.
During replication, the genome is expressed as a single open reading
frame (ORF) that is processed into mature polypeptide products.
Translation of the ORF begins with a proteinase (Lpro), which is followed
by the structural proteins of the P1 region (1A, 1B, 1C, and 1D) and the
remainingnonstructural proteins of the P2 (2A, 2B and2C) andP3 regions
(3A, 3B, 3Cpro, and 3Dpol) (Grubman and Baxt, 2004). The 3C protease is
responsible for most of the cleavages during the FMDV polyprotein
processing (Vakharia et al., 1987), and 3Dpol is the viral RNA-dependent
RNA polymerase (Grubman and Baxt, 2004). Protein 3B is covalently
bound to the 5′ end of the genome and antigenome, and functions in
priming picornavirus RNA synthesis (Wimmer, 1982). In addition to the
four terminal P3 cleavage products (3A, 3B, 3C, and 3D proteins) and the
uncleaved P3 polyprotein, several “intermediates” are observed in
infected cells (3AB, 3CD, and 3BCD proteins) (Oh et al., 2009). As
reviewed by Oh et al. (2009), it has been shown for poliovirus that theseintermediate cleavage products of the P3 region can have different
functions from their terminal cleavage products (3A, 3B, 3C and 3D).
In FMDV, 3B is present in three similar but nonidentical copies (3B1,
3B2 and 3B3) (Forss and Schaller, 1982) that are 23 or 24 amino acids in
length (King et al., 1980). Although not all three copies of FMDV 3B are
needed to maintain infectivity (Falk et al., 1992; Pacheco et al., 2003),
there are no reports of naturally occurring FMDV strains with fewer than
three copies of 3B, suggesting that there is a strong selective pressure
toward maintaining this redundancy (Carrillo et al., 2007; MacKenzie
et al., 1975). This is an unusual ﬁnding, since FMDV is known to readily
undergo homologous recombination to remove redundant genetic
material (King et al., 1982). However, it has been reported that deletion
of the 3B3 coding sequencewithin the context of the full-length infectious
cDNA resulted in the production of a noninfectious RNA transcript (Falk
et al., 1992). Additionally, 3B3 seems to be themost efﬁcient substrate for
the FDMV 3Dpol activity when each of the FMDV 3Bs is uridylylated in
vitro (Nayak et al., 2005). It has been described that the loss of 3B3
sequence may also have a deleterious effect on FMDV RNA replication
(Nayak et al., 2005). Laboratory-generated viruses lacking theﬁrst two 3B
peptides were impaired in their ability to replicate in porcine cells in
culture and caused attenuated disease in pigs showing that the presence
of three 3Bs appear to control the virus’ pathogenic potential and host
range (Pacheco et al., 2003).
In this work we analyzed the in vitro and in vivo characteristics and
pathogenic potential of viruses derived from a FMDV A24 Cruzeiro full-
length cDNA infectious clone (A24-WT) containing modiﬁed forms or
deletion of individual 3B peptides. Three viruseswere created carrying an
in-frame 57-nucleotide (19 amino acid) insertion randomly located into
150 J.M. Pacheco et al. / Virology 405 (2010) 149–156one of the three different 3Bs resulting in severe disruption of the native
amino acid sequence of the target proteins. Two additional viruses were
also obtained which eliminated not only the 57 nucleotide transposon
insertion after transfection but also had a partial deletion of the 3B region
(3′ end of 3B1 and 5′ end of 3B2, in both cases). Interestingly, our results
demonstrated that all 5 mutant viruses grew similarly, showed similar
RNA replicationkinetics andhad similar plaque size in cell culture to those
of theparental virus. Additionally, cattle infectedbyaerosol exposurewith
each of the ﬁve viruses developed infection and clinical disease similar to
that caused by the parental FMDV A24-WT. Therefore, we provide
evidence that the introduction of signiﬁcant individual domain alterations
on each of the 3B proteins do not have a signiﬁcant effect on virus growth
in vitro nor in virus virulence in vivo.
Results
Generation of FMDV 3B mutants
Using a full-length FMDV A24-WT cDNA clone (Rieder et al., 2005),
nine plasmids containing 19mer inserts in the 3B region were generated
by random transposon mediated insertion mutagenesis. Mutated plas-
mids were completely sequenced to conﬁrm the exact insertion site. RNA
derived from each of nine plasmids containing individual insertions in
eachof the 3Bproteinswere use for electroporation of BHK-21 cells giving
origin to ﬁve viruses showing either insertions or deletions in 3B and
additional changes elsewhere in the genome after ampliﬁcation in BHK-
21 cells (Table 1). Viruses derived fromplasmids pA24-VPg1-5873, pA24-
VPg2-5934 and pA24-VPg3-6007 harbored individual inserts in one of
their 3B proteins and were named A24-VPg1-5873, A24-VPg2-5934 and
A24-VPg3-6007 respectively (Fig. 1A). Two plasmids with inserts in 3B1
(pA24-VPg1-5853 and pA24-VPg1-5869) yielded viruses that lost the
original insert alongwith one full 3B, including the3′ endof 3B1 and the5′
end of 3B2 resulting in mutant viruses A24-ΔVPg-5853 and A24-ΔVPg-
5869, respectively (Fig. 1B). The full-length genome of the ﬁve mutant
viruses was sequenced and showed very few differences throughout the
genome besides their 3B insertions or deletions (Table 1).
Cell growth characteristics of FMDV 3B mutants
The growth kinetics of the ﬁve mutant viruses was compared with
the parental virus A24-WT in EBK cells (primary embryonic bovine
kidney cells). Cell cultureswere infectedwith each of the viruses at high
and low multiplicity of infection (MOIs) (5, 0.1 and 0.01). At different
time points post-infection samples were taken and titrated on BHK-21Table 1
Nucleotide and amino acid sequence of mutant viruses obtained after transfection or from
Nucleotide and amino acid changes rela
Plasmid Virus obtained in cell
culture
5'UTR(d) VP1 3D
542(e) 924 3730 6752
pA24-WT FMDV A24-WT A T C (Ala) C (Leu)
pA24-VPg1-5853 A24-ΔVPg-5853(a) A T T (Ala) T (Leu)
pA24-VPg1-5869 A24-ΔVPg-5869(b) A T C (Ala) T (Leu)
pA24-VPg1-5873 A24-VPg1-5873 A - C (Ala) T (Leu)
pA24-VPg2-5934 A24-VPg2-5934 C T C (Ala) T (Leu)
pA24-VPg3-6007 A24-VPg3-6007 A T C (Ala) T (Leu)
a Virus with deletion at nt 5829–5897.
b Virus with deletion at nt 5856–5924.
c Full-length genome sequencing of 6 high titer stock viruses was performed.
d Virus region.
e Nucleotide position.
f Partial sequence including only the 3B region of viruses obtained from cows during th
wild-type.
g Viruses from clinical samples collected from this cow were partially sequenced and they
3B2, resulting in a virus similar to the A24-ΔVPg viruses.cells. At all MOIs mutant viruses demonstrated growth kinetics similar
to that of the parental virus (Fig. 2). All viruses obtained at 24 h time
point from the growth curve generated with an MOI of 0.01 were full-
length sequenced to conﬁrm that the original insertions and deletions
were still present in a mostly homogeneous viral population. No
changes were detected in any of the viruses analyzed (results not
shown).
Plaque morphology of the FMDV 3Bmutant viruses was evaluated on
ﬁve FMDV susceptible cell lines: BHK-21 (hamster kidney-derived cells),
BHK- αVβ6 (BHK-21 cells constitutively expressing bovine integrins
(Duque et al., 2004)), IBRS2 (swine-derived cell line), LFBK (bovine-
derived cell line (Swaney, 1988)) and EBK. No signiﬁcant differences in
the titer (Fig. 3A) or plaque sizes were found, with the exception of A24-
VPg3-6007 that showed a 40–50% smaller plaque size in BHK-21, BHK-
αVβ6 and EBK cells, but not in LFBK or IBRS2 cells (Fig. 3B).
Kinetics of viral RNA synthesis in FMDV with altered 3B proteins
The effect of modiﬁcations in 3B proteins on viral RNA synthesis
during infection of BHK-21 and EBK cell was analyzed. Cultures were
infected with each of the mutant or parental A24-WT viruses at anMOI
of 5 and 0.05. Total intracellular FMDV RNA concentrations were
determined by quantitative rRT-PCR (Callahan et al., 2002) at different
sampling points during the ﬁrst 4 h post-adsorption. Mutant viruses
showed similar pattern of RNA synthesis to A24-WT at both low and
high MOI in both cell types. Only a small delay in RNA synthesis at 1–2
h post-adsorption in BHK-21 cells was observed in mutant A24-Vpg3-
6007 (Fig. 4).
Processing of 3A and 3B proteins in FMDV 3B mutants
Since 3B is too small to be readily resolved by standard polyacryl-
amide gel electrophoresis, its presence is usually visualized in partially
processed intermediates (Falk et al., 1992; Pacheco et al., 2003). Top (I)
and center (II) portions of Fig. 5 show aWestern blot developed using a
rabbit polyclonal serum that recognizes the conserved N-terminal
portion of 3A (O'Donnell et al., 2001). The bottom portion (III) of Fig. 5
shows reactivity with a pool of monoclonal antibodies against 3B to
conﬁrm the assignmentof productsmadeon the top and centerportions
of theﬁgure. A typical A24-WTelectrophoretic pattern showsﬁve 3A-3B
proteins and the mobility observed for these proteins was slightly
slower than predicted, as previously reported (Garcia-Briones et al.,
2006; O'Donnell et al., 2001; Pacheco et al., 2003; Strebel et al., 1986).
The fastest migrating band (band 1) represents degraded-3A (Pachecoclinical samples.
ted to FMDV A24-WT(c)
Partial sequence (3B region) of
viruses obtained from infected animals(f)
6952 7041 7294
T (Val) A (Glu) T (Pro)
C (Val) A (Glu) T (Pro) No change in sequence
T (Val) A (Glu) C (Pro) No change in sequence
T (Val) C (Ala) T (Pro) No change in sequence
or deletion at nucleotides
5842–5878 and 5936–5967(g)
T (Val) A (Glu) T (Pro) No change in sequence
T (Val) A (Glu) T (Pro) No change in sequence
e acute stage of the disease (days 4–6 post-inoculation) to conﬁrm non-reversion to
either retained the insert in 3B or contained deletions of the 3′ end of 3B1 and 5′ end of
Fig. 1. Diagram of FMDV A24-3B mutants named based on the location of the mutation in pA24-WT. (A) Transposon-containing mutants with altered 3B protein shown for each
virus. Remaining 3B amino acid sequences are the same as the parental virus (A24-WT). The amino acid at which the insertion occurred is marked with the dotted line. (B) Deletion-
containing mutants. Solid line indicates where deletion took place and separates original regions of 3B1 (to the left) and 3B2 (to the right) in the resulting viruses.
151J.M. Pacheco et al. / Virology 405 (2010) 149–156et al., 2003) and the remaining four bands correspond to 3A (band 2),
3AB1 (band 3), 3AB1B2 (band 4) and 3AB1B2B3 (band 5). In order to
better visualize several weak bands a longer exposure of the same gel is
shown in top portion of Fig. 5. Doublets observed (e.g. bands 3 and 4)
could result from incomplete reduction of these proteins (Garcia-
Briones et al. (2006)) or from uridylation of the 3B portion of the
proteins or unspeciﬁc protease activity as previously described by
Strebel et al. (1986). All 3B containing bands (3, 4 and 5) were alsoFig. 2.Multi-step growth curve of either A24-mutants or A24-WT viruses. EBK cell cultures
titers were performed on BHK-21 cells and expressed as TCID50/ml on BHK-21 cells. Valuesvisualized with anti-3B antibodies (Fig. 5, panel III). The two mutants
with one 3B deleted (A24-ΔVPg) showed the same bands 1 and 2 as
A24-WT, and two bands very similar in size to bands 3 and 4
corresponding to 3AB1/2 (band 6) and 3AB1/2B3 (band 7) respectively.
As expected, a band corresponding to the formwith three 3Bs (band 5)
was absent in these viruses as conﬁrmed in longer ﬁlm exposures (top
portion). In these two mutants only one 3B band was detected by anti-
3B antibodies, suggesting that the 3AB1/2B3 (band 7) is not recognizedwere infected at an MOI 5 (top panel), 0.1 (center panel) or 0.01 (bottom panel). Virus
are averages and standard deviations representative of two independent experiments.
Fig. 3. (A) Ability of the FMDV A24 3B mutant viruses to form plaques in cell cultures
derived from different animal species. PFU/ml values were determined starting with
viruses at dilutions containing 107 PFU/ml, as previously determined in BHK-21 cells.
Values are averages and standard deviations representative of two independent
experiments. (B) Plaque size assessment of either A24-mutants or A24-WT viruses on
BHK-21, BHK- αVβ6, LFBK, IBRS2 and EBK cells. Cells were infected and after 1
h adsorption, 0.6% gum tragacanth overlay was added, followed 48 h later with crystal
violet staining.
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an insert in 3B1, showed bands 1 and 2 without modiﬁcations and a
single band (identiﬁed as band 8) co-migrating with band 3 (3AB1) of
A24-WT. We expected band 8 to be a product of larger size than band 3
due to the presence of the transposon insert, but a putative 3C cleavage
site (www.expasy.org/tools/peptidecutter) presentwithin the3′ endof
the insert itself may have resulted in a 3AB product similar in size to
wild-type 3AB1. Additionally for this virus, differences were found with
respect to A24-WT in the processing of the 3′ end of P3 after the
transposon (bands 9 and 10). However, all 3B containing putative bands
(8, 9 10) were detected by anti-3B antibodies (Fig. 5, panel III). Virus
A24-VPg2-5934 showed bands 1–3 as A24-WT and band 11 co-
migrating with band 4. Again, we expected a larger 3AB1B2 due to the
presence of the transposon insert in 3B2, but putative 3C cleavage sites
within the transposon might explain the smaller than expected 3AB1B2
(band 11). Similar towhat is described for A24-VPg1-5873, the 3′ end of
P3 showed a different pattern than A24-WT (bands 12 and 13) but all
putative 3B containing bands reacted with anti-3B (Fig. 5, panel III).
Virus A24-VPg3-6007 showed bands 1–4 same as A24-WT, band 14
likely formed by cleavage within the transposon and 3AB1B2B3-19merand an unknown processing pattern for the 3′ end of P3 (band 15), all
reactive with anti-3B antibodies (Fig. 5, panel III). Mock inoculated cells
conﬁrmed the speciﬁcity of the antibodies used in the Western blot.
When analyzed with a pool of monoclonal antibodies against 3C no
bands were detected, indicating that cleavage at site 3B3/3C is not
affected by the presence of the insert or deletions (results not shown).
Taken together, these results indicate thatwith thepresence of deletions
or insertions in 3B, mutant FMD viruses yield different 3AB protein
products in infected BHK-21 cells.
Assessment of FMDV 3B mutant virulence in cattle
Virulence of mutants and parental A24-WT was assessed utilizing a
well establishedaerosolization inoculationmethod that resemblesnatural
infection (Pacheco et al., 2008). Cows were inoculated with 107 TCID50 of
mutant or parental A24-WT and viral infection and clinical signs were
monitored daily (Pacheco et al., 2008). Results demonstrated that all ﬁve
animals, each inoculatedwithoneof themutantvirusesdevelopedclinical
FMD as did the A24-WT infected animal and all reached a maximum or
close to themaximum clinical score by the end of the study (9 days post-
infection (dpi). However, fever was sporadic and the appearance of
clinical signs was delayed in animals inoculated with 3B mutants
compared to the animal inoculated with A24-WT. Interestingly, while
viremia lasted three days in the cow inoculated with FMDV A24-WT, as
well as in cows inoculated with mutants A24-ΔVPg-5869 and A24-VPg1-
5873, cows inoculated with the three remaining mutant viruses (A24-
ΔVPg-5853, A24-VPg2-5934 and A24-VPg3-6007), presented a viremia
that lasted one or two days. Virus shedding (from saliva) was detected in
all animals from 2 to 8 dpi, with the exception of the animal inoculated
with A24-VPg2-5934,where viruswas detected in very low amounts only
at 2 and 6 dpi. Serumneutralizing antibodieswere detected in all animals
starting at 5 or 6 dpi (Fig. 6). Table 1 shows partial genomic sequence of
multiple viruses recovered from lesions in animals inoculated with 3B
mutant viruses conﬁrming that the diseasewas caused bymutant viruses
and not by reversions to wild-type virus. The only exception was a virus
from one of ﬁve samples obtained from the animal inoculated with A24-
VPg1-5873. This virus had not only lost the insert but also removed an
entire 3B, a similar mutation previously seen with the two 3B deletion
mutants described above (A24-ΔVPg-5853 and A24-ΔVPg-5869).
Discussion
Among the picornaviruses, FMDV has a unique genomic feature: the
presence of redundant copies of the 3B protein. This redundancy was
analyzed in the past. Falk et al. reported that although not all three copies
of 3B are needed to maintain infectivity, 3B copy number inﬂuences RNA
synthesis andproductionof infectious FMDVparticles in cell culture. Their
3B deletedmutants had reduced viral RNA synthesis levels after infection
and the levels of viral RNA synthesis and infective particle formationwere
found to correlate with the number of functional 3Bs left in the mutant
viruses. These authors suggested a direct correlation of 3B gene dosage
and viral RNA synthesis, with a secondary effect on infective particle
formation (Falk et al., 1992). In poliovirus, it was shown that the 3B
uridylylation reactionmay employ a 3B-containing precursor (3AB or 3BC
(D)) rather than the processed 3B (Liu et al., 2007; Oh et al., 2009; Pathak
et al., 2008). Based on these reports, it could be hypothesized that the
presence of three 3Bs could beneﬁt FMDV replication due to the additive
presence of multiple 3B or 3B-precursors proteins.
Toaddress the importanceof 3B inviral virulence, particularly in cattle,
one of themain natural FMDVhosts,we created viruseswith insertions in
each of the 3B proteins aswell as viruseswith only two 3Bs in the genetic
backbone of FMDV A24-WT, a virus that is fully virulent in cattle. It is
important to note that each 3B protein was disrupted by the insertion of
anaminoacid sequence (19mer) similar in size toa single3Bprotein itself.
Therefore it is expected that this insertion severely altered the structure
and affected the function of the individual 3B.
Fig. 4. Synthesis of viral intracellular RNA in cell cultures infected with either FMDV A24-3B mutants or parental virus. Values are expressed as amounts of RNA copy numbers
recovered from BHK-21 and EBK cell cultures infected at an MOI of 5 or 0.05, and quantiﬁed by rRT-PCR. Data represents values and error bars from data obtained in an independent
experiment. Experiments were reproduced at least three times.
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and 3B could decrease RNA synthesis and virus yield in different cell
lines, particularly in bovine-derived cells (O'Donnell et al., 2001;
Pacheco et al., 2003). It has also been described that expression of 3AB
proteins resulted in an increase of FMDV replication in vitro, suggesting
that the redundancyof 3Bmaybe relatedwith simultaneouspresence of
3AB and 3B that would improve FMDV replication and translation
(Rosas et al., 2008). Nevertheless, here we could not ﬁnd signiﬁcant
differences in the level of RNA synthesis among all mutants when
compared with the parental virus. Similar results were obtained when
the growth abilities of the mutant viruses were analyzed in single or
multistep growth curves. Thus, in our hands, severe domain disruptions
in individual 3B proteins did not signiﬁcantly affect the ability of FMDV
to synthesize viral RNA nor to replicate and grow in susceptible cell
lines.
Each of the three distinct FMDV 3B peptides is an efﬁcient substrate in
the FMDV VPgpU(pU) uridylation reaction, but 3B3 has been shown to
have the highest activity (Nayak et al., 2005). Although it has been
reported that modiﬁcations of the 3B3 coding sequence result in
production of a noninfectious RNA transcript (Falk et al., 1992), we
were able to derive a viral mutant containing a severe disruption of 3B3
(A24-Vpg3-6007), albeit this virus showed a slight delay in viral growth.
It has been shown that Tyr-3 of 3B is critical in the process of
poliovirus replication (Kuhn et al., 1988a,b; Liu et al., 2007; Paul et al.,
2003; Reuer et al., 1990). Consistent with these previous results, our
plasmid constructs containing inserts near the Tyr-3 residue of 3B2 or
3B3 (pA24-VPg2-5887, pA24-VPg2-5889, pA24-VPg2-5949 and pA24-
VPg3-5974), yielded viruses that had reverted to wild-type genotype or
did not yield viable progeny, despite the fact that theother two3Bswere
not affected (not shown).
To determine whether insertions or deletions in the individual 3Bs
altered the processing of the P3 region, we analyzed the proteolytic
cleavage products of the ﬁve mutant viruses in vitro. All 3B mutants
maintained processing of P3 region (3A, 3B and 3C (not shown))
although an altered pattern of 3B protein processing was observed in
somemutant viruses. Our proposed interpretation of the band patterns
observed in Fig. 5 was based on the size and reactivity of these bandswith speciﬁc anti-3A and anti-3B antibodies and previous studies
documenting this processing (Pacheco et al., 2003).
In previouswork itwas reported that FMDVcontaining only oneof the
3B proteins was partially attenuated when inoculated in swine (Pacheco
et al., 2003). It has been suggested that there is an association between 3B
copy number and virulence in vivo and thismay explainwhy three copies
of 3B are present in all FMDV strains characterized to date (Carrillo et al.,
2007;MacKenzie et al., 1975). In contrast, when viruses were analyzed in
vivo in this study, virulence was not drastically decreased in the 3B
mutants compared to the parental wild-type FMDV except for some
minor delays in the appearance of viremia and clinical signs and extent of
shedding. Therefore, in our hands FMDV appears to have considerable
ﬂexibility in accepting insertions and deletions of the 3B region. Our
results indicate that as long as two functional 3Bs (viruses A24-ΔVPg-
5853 and A24-ΔVPg-5869) were maintained, the virus was able to
replicate in vitro and cause disease in cattle. Although our data might
suggest that two copies of 3B are sufﬁcient for FMDV virulence, theminor
delays in establishing infection and decreased shedding may be
detrimental during the natural transmission cycle preventing these
mutations to be maintained. Interestingly the mutants with 3B deletions
(A24-ΔVPg-5853 and A24-ΔVPg-5869) combined parts of 3B1 and 3B2
while always conserving 3B3 intact. This was also true in the deletion
mutant virus recovered froma cow inoculatedwith virus A24-VPg1-5873.
This couldbedue to the similarityof theﬁrst two3Bsor to the critical need
for 3B3 for adequate FMDV replication, as has been previously suggested
(Nayak et al., 2005).
In summarywe present data showing that severe domain disruptions
of individual 3B proteins do not drastically affect FMDV RNA synthesis,
virus replication or virulence in cattle. It is remarkable that the
introduction of a 19 amino acid insert in a 23–24 amino acid protein
does not appear to interfere with the basic viral activity during in vitro
replication or even causing disease in cattle. The independence of FMDV
virulence from the presence of three intact 3B proteins is difﬁcult to
reconcile with the conserved presence of these three proteins across
hundreds of FMDV strains in all seven serotypes sequenced to date,
suggesting that the redundancy of these genomic elements is required for
viral processes not measured in this study.
Fig. 5.Western blot to detect 3A and 3B proteins. Lysates of BHK-21 cells infected with either A24-3B mutants or parental virus were separated on SDS-PAGE. Western blotting was
performed using a speciﬁc rabbit polyclonal serum against the N-terminal portion of 3A of FMDV-A12 (panels I and II) or monoclonal antibodies against FMDV 3B (panel III).
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Construction of transposon-containing FMDV mutants
To identify virulence determinants within the FMDV genome, we
constructed a library of infectious FMDV full-length genome plasmids
of pA24Cru (Rieder et al., 2005) containing single random insertions
(1 per genome), using the EZ-Tn5™ Insertion Kit (Piccone et al., 2009;
Piccone et al., 2010). Plasmids containing a 57 nt insertion in the 3B
encoding region were selected for further study. Each of these
plasmids contained an insertion at residues 5853, 5869, 5873, 5887,
5889, 5934, 5949, 5974 or 6007 and were named according to the
mutation location in 3B, as pA24-VPg1-5853, pA24-VPg1-5869, pA24-
VPg1-5873, pA24-VPg2-5887, pA24-VPg2-5889, pA24-VPg2-5934,
pA24-VPg2-5949, pA24-VPg3-5974 and pA24-VPg3-6007, respective-
ly. All nucleotide designations are based on the nucleotide sequence of
A24 Cruzerio. T7 RNA transcripts of SwaI-linearized plasmids,
including pA24Cru, were produced using a MegaScript T7 Kit
(Ambion, Austin, Texas) followed by subsequent transfection into
BHK-21 cells by electroporation as described previously (Piccone
et al., 1995; Rieder et al., 1993). Mutant viruses obtained from these
transfections were named according to the site of insertion (see
below).
Cells and viruses
Viruses containing single in-frame insertions or deletions in the 3B
region were derived from the mutant plasmids and the A24-WT
described above. In order to maintain adequate bovine receptor usage,
virus stocks were grown in a derivative of baby hamster kidney (BHK-
21) (baby hamster kidney cell line, ATCC, catalogue number CCL-10)
cells expressing the bovine αVβ6 integrin (BHK-αVβ6) (Duque et al.,2004) and titrated on BHK-21 cells by calculating the 50% tissue culture
infectious dose perml (TCID50/ml). Two of the plasmids yielded viruses
containingone insert in 3Bnamely A24-VPg2-5934 andA24-VPg3-6007.
Two other plasmids gave origin to viruses that lost the insert and a full
3B and these viruses were named A24-ΔVPg-5853, A24-ΔVPg-5869,
respectively. After several attempts, the remainingﬁve plasmids (pA24-
VPg1-5873, pA24-VPg2-5887, pA24-VPg2-5889, pA24-VPg2-5949 and
pA24-VPg3-5974) gave no progeny or yielded viruses that had reverted
to wild-type genotype when grown in BHK-αVβ6 cells with subsequent
culturing in BHK-21 cells. The only virus with an insert obtained in a
second round of transfections was A24-VPg1-5873. Virus stocks were
prepared with A24-WT, A24-ΔVPg-5853, A24-ΔVPg-5869, A24-VPg1-
5873, A24-VPg2-5934 and A24-VPg3-6007 and the complete viral
sequence was determined using FMDV-speciﬁc primers designed to
cover the entire genome. High titer stocks were determined in BHK-21
cells. In vitro phenotype was characterized by plaque assays in BHK-21
cells, BHK-αVβ6 cells, a bovine kidney cell line (LFBK) (Swaney, 1988), a
porcine kidney cell line (IBRS2) (de Castro, 1964) and primary
embryonic bovine kidney cells (EBK, kindly provided by Dr S.Wessman,
USDA, APHIS, AMES, Iowa).
Comparative ability to grow and to form plaques
In order to characterize in vitro growth, plaque assays were
performed in the 5 different cell types described above (BHK-21, BHK-
αVβ6, IBRS2, LFBK and EBK cells) with the 6 selected viruses described
above (FMDV A24-WT, A24-ΔVPg-5853, A24-ΔVPg-5869, A24-VPg1-
5873, A24-VPg2-5934 and A24-VPg3-6007) to compare plaque size and
ability to replicate in the different cell types. The ability of these viruses
to replicate in different cell types was determined by testing serial 10-
fold dilutions of virus (starting with 107 PFU/ml [as measured
previously on BHK-21 cells]) to form plaques on these different cells.
Fig. 6. Comparison of disease induced in cattle by either A24-3Bmutants or A24-WT viruses. Animals were inoculated with aerosol containing 107 TCID50. Viremia (■), virus in saliva
(▲) and serum-neutralizing antibody titers (X) are expressed in the left axes; the clinical score (bars) are expressed in the right axes. + denotes fever (N40 °C).
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dilutions of eachvirus. Tragacanth gumoverlay (0.6%)was added after 1
h adsorption and after 48 h the plates were ﬁxed and stained with
crystal violet. Analyses were performed side-by-side with BHK-21 cells,
and the resulting data was used to calculate the PFU/ml. All samples
were run simultaneously to avoid inter-assay variability.
Virus growth curve in primary tissue culture
Growth curves were performed in EBK cells. Preformed monolayers
were prepared in 24-well plates and infected with the six viruses
described above (A24-WT, A24-ΔVPg-5853, A24-ΔVPg-5869, A24-VPg1-
5873, A24-VPg2-5934 and A24-VPg3-6007) at MOIs of 5, 0.1 and 0.01
(based on TCID50 previously determined in BHK-21 cells). After 1 h of
adsorption at 37 °C the inoculumwas removed and the cells were rinsed
two times with ice-cold 145 mM NaCl, 25 mM MES (pH 5.5) to remove
residual virus particles. The monolayers were then rinsed with media
containing 1% fetal calf serum and 25 mM Hepes (pH 7.4) and incubated
for 0, 4, 8 and 24 h at 37 °C. At appropriate times post-infection, the cells
were frozen at −70 °C and the thawed lysates were used to determine
titers by TCID50/ml on BHK-21 cells.
Determination of intracellular viral RNA concentration
BHK-21 and EBK cells were seeded in 24-well plates, infected at MOIs
of 0.5 and5with all 6 viruses (A24-WT,A24-ΔVPg-5853,A24-ΔVPg-5869,
A24-VPg1-5873, A24-VPg2-5934 and A24-VPg3-6007), adsorbed and acidwashed as described above. After 0, 0.5, 1, 2 and 4 h incubations at 37 °C,
cell supernatants were discarded and total cellular RNA was extracted
frommonolayers with Lysis/Binding Solution (Ambion, Austin, TX), then
frozen until further use. Quantitation of FMDV RNA was performed by
rRT-PCR as previously described (Pacheco et al., 2008). Three separate
experiments were performed and CT values converted to the number of
RNA copies/ml based on FMDVRNA speciﬁc calibration curves developed
with in vitro- synthesized RNA.
Western blot analyses of 3A and 3B polypeptides in infected cells
BHK-21 cells were infected with every mutant and parental A24
viruses at an MOI of 5 and when 60–70% of the cells displayed CPE
(approximately 6 hpi) the supernatant was discarded and the cell
monolayers were lysed with TNET buffer (10 mM Tris [pH 7.5], 150 mM
NaCl, 1 mM EDTA, 1% [wt/vol] Triton X-100) for 20 min on ice; after
clariﬁcation, the cell lysateswere stored at−70 °C. Sampleswere resolved
by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels
(NuPAGE® Novex® Bis-Tris Mini Gels; Invitrogen) and electroblotted
onto polyvinylidene diﬂuoride membranes (Millipore) by standard
methods. FMDV-speciﬁcproteinsweredetectedwithachemiluminescent
Western Blot immunodetection kit (WesternBreeze®, Invitrogen). For
detection of the different forms of 3AB, a polyclonal rabbit serum
generated by using an Escherichia coli-expressed N-terminal fragment of
3A of FMDV-A12 (O'Donnell et al., 2001) diluted 1/500 was used as the
primary antibody. Fordetectionof 3B apool ofmonoclonal antibodieswas
used as the primary antibody diluted 1:500 (monoclonals 1G7 and 1A10,
156 J.M. Pacheco et al. / Virology 405 (2010) 149–156kindlyprovidedbyDr. E. Brocchi). Fordetectionof 3Capool ofmonoclonal
antibodies was used as the primary antibody diluted 1:500 (monoclonals
2B7 and 1H6, kindly provided by Dr. E. Brocchi).
Viral virulence in cattle, serology and virus isolation
Cattle experimentswere performedunder Biosafety level 3 conditions
in the animal facilities at PIADC following a protocol approved by the
Institutional Animal Use and Care Committee. Steers (300–400 kg) were
infected using an aerosolization method that resembles natural infection
(Pacheco et al., 2008). Brieﬂy, animals were sedated and inoculated with
107 TCID50 in 2 ml of MEM delivered by aerosol with a jet nebulizer
(Whisper Jet, Marquest Medical Products, CO) attached to an aerosol
delivery system (Equine Aeromask, Medium Size, Trudell Medical,
London, ON, Canada). One steer per virus (FMDV A24-WT, A24-ΔVPg-
5853, A24-ΔVPg-5869, A24-VPg1-5873, A24-VPg2-5934 and A24-VPg3-
6007) was inoculated and held in individual animal rooms. Steers were
clinically examined, including rectal temperature recordings, for 9 days
after inoculation, and then humanely euthanized. Serum and oral swabs
were collected and cows were sedated daily for clinical evaluation. After
collection, samples were aliquoted and frozen at −70 °C. Neutralizing
antibody titers in serumwere determined as described elsewhere (Golde
et al., 2005). Brieﬂy, serial dilutions of serumwere incubated with a virus
dose of 100 TCID50 of FMDV A24 for 1 h at 37 °C and then BHK-21 cells
were added on top and incubated at 37 °C for 48–72 h. End-point titers
were calculated as the reciprocal of the last serum dilution to neutralize
100 TCID50 of virus in 50% of the wells. One serum and one swab aliquot
wereused toperformviral titrationonBHK-21 cells by calculating the50%
tissue culture infectious dose per ml (TCID50/ml) as described elsewhere
(Pacheco et al., 2003). Clinical scoring, with a maximum of 20, was
performed based on severity of lesions on the four feet, the snout, and the
mouth as described elsewhere (Pacheco et al., 2008).
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